251 related articles for article (PubMed ID: 23194889)
1. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs.
He W; Lu Y; Qi J; Chen L; Hu F; Wu W
Int J Pharm; 2013 Jan; 441(1-2):269-78. PubMed ID: 23194889
[TBL] [Abstract][Full Text] [Related]
2. Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution.
He W; Lu Y; Qi J; Chen L; Yin L; Wu W
Int J Nanomedicine; 2013; 8():3119-28. PubMed ID: 23983465
[TBL] [Abstract][Full Text] [Related]
3. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
4. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
5. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
Mou D; Chen H; Wan J; Xu H; Yang X
Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
Verma S; Gokhale R; Burgess DJ
Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
Kocbek P; Baumgartner S; Kristl J
Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
[TBL] [Abstract][Full Text] [Related]
8. Study of effect of variables on particle size of telmisartan nanosuspensions using box-Behnken design.
Rao MR; Bajaj A
Drug Res (Stuttg); 2014 Dec; 64(12):663-7. PubMed ID: 24549965
[TBL] [Abstract][Full Text] [Related]
9. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
10. Tea saponins as natural stabilizers for the production of hesperidin nanosuspensions.
Long J; Song J; Zhang X; Deng M; Xie L; Zhang L; Li X
Int J Pharm; 2020 Jun; 583():119406. PubMed ID: 32387309
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of amorphous curcumin nanosuspensions using β-lactoglobulin to enhance solubility, stability, and bioavailability.
Aditya NP; Yang H; Kim S; Ko S
Colloids Surf B Biointerfaces; 2015 Mar; 127():114-21. PubMed ID: 25660094
[TBL] [Abstract][Full Text] [Related]
12. Nanosuspensions of a poorly soluble investigational molecule ODM-106: Impact of milling bead diameter and stabilizer concentration.
Singhal M; Baumgartner A; Turunen E; van Veen B; Hirvonen J; Peltonen L
Int J Pharm; 2020 Sep; 587():119636. PubMed ID: 32659405
[TBL] [Abstract][Full Text] [Related]
13. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.
Yang H; Teng F; Wang P; Tian B; Lin X; Hu X; Zhang L; Zhang K; Zhang Y; Tang X
Int J Pharm; 2014 Dec; 477(1-2):88-95. PubMed ID: 25455766
[TBL] [Abstract][Full Text] [Related]
14. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
16. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
17. Preparation of azithromycin nanosuspensions by reactive precipitation method.
Hou CD; Wang JX; Le Y; Zou HK; Zhao H
Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
[TBL] [Abstract][Full Text] [Related]
18. Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in vitro characterization, and pharmacokinetics in rats.
He W; Tan Y; Tian Z; Chen L; Hu F; Wu W
Int J Nanomedicine; 2011; 6():521-33. PubMed ID: 21468355
[TBL] [Abstract][Full Text] [Related]
19. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.
Xu Y; Liu X; Lian R; Zheng S; Yin Z; Lu Y; Wu W
Int J Pharm; 2012 Nov; 438(1-2):287-95. PubMed ID: 22989976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]